Therapeutic vaccination against HIV : current progress and future possibilitiesPULS, Rebekah L; EMERY, Sean.Clinical science (1979). 2006, Vol 110, Num 1, pp 59-71, issn 0143-5221, 13 p.Article

Selective exclusion of treatment arms in multi-arm randomized clinical trialsLAW, Matthew G; EMERY, Sean.Statistics in medicine. 2003, Vol 22, Num 1, pp 19-30, issn 0277-6715, 12 p.Article

Epilogue : Preparing for an influenza pandemic in AustraliaEMERY, Sean; DWYER, Dominic E; MCKINNON, Moira et al.Medical journal of Australia. 2006, Vol 185, Num 10, issn 0025-729X, p. S80, SUPArticle

Preparing for an influenza pandemicDWYER, Dominic E; EMERY, Sean; MCKINNON, Moira et al.Medical journal of Australia. 2006, Vol 185, Num 10, issn 0025-729X, 56 p., SUPSerial Issue

Ethical issues in pandemic planningTORDA, Adrienne.Medical journal of Australia. 2006, Vol 185, Num 10, issn 0025-729X, S73-S76, SUPArticle

Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trialsCAREY, Dianne; AMIN, Janaki; BOYD, Mark et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 9, pp 1878-1888, issn 0305-7453, 11 p.Article

Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwardsMURRAY, John M; MCBRIDE, Kristin; KOELSCH, Kersten K et al.AIDS (London). 2012, Vol 26, Num 5, pp 543-550, issn 0269-9370, 8 p.Article

Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive, HIV-1―Infected Individuals Commencing cART? A Randomized, Controlled StudyWINSTON, Alan; DUNCOMBE, Chris; LI, Patrick C. K et al.Clinical infectious diseases. 2010, Vol 50, Num 6, pp 920-929, issn 1058-4838, 10 p.Article

A Randomized, Multicenter, Open-Label Study of Poly-L-Lactic Acid for HIV-1 Facial LipoatrophyCAREY, Dianne L; BAKER, David; ROGERS, Gary D et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 5, pp 581-589, issn 1525-4135, 9 p.Article

Infection control and pandemic influenzaCOLLIGNON, Peter J; CARNIE, John A.Medical journal of Australia. 2006, Vol 185, Num 10, issn 0025-729X, S54-S57, SUPArticle

HIV disease progression in a patient cohort treated via a clinical research network in a resource limited settingDUNCOMBE, Chris; KERR, Stephen J; RUXRUNGTHAM, Kiat et al.AIDS (London). 2005, Vol 19, Num 2, pp 169-178, issn 0269-9370, 10 p.Article

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial. CommentaryCARR, Andrew; WORKMAN, Cassy; COOPER, David A et al.Lancet (British edition). 2004, Vol 363, Num 9407, pp 412-414, issn 0140-6736, 13 p.Article

CD4 cell response to 3 doses of subcutaneous interleukin 2: Meta-analysis of 3 Vanguard studiesARDUINO, Roberto C; NANNINI, Esteban C; TAVEL, Jorge A et al.Clinical infectious diseases. 2004, Vol 39, Num 1, pp 115-122, issn 1058-4838, 8 p.Article

Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNγ or IL-12DALE, C. Jane; DE ROSE, Robert; EMERY, Sean et al.Vaccine. 2004, Vol 23, Num 2, pp 188-197, issn 0264-410X, 10 p.Article

Interleukin-2 in clinical trials : Other factors to be considered. Authors' replyNANNINI, Esteban C; EMERY, Sean; LANE, H. Clifford et al.The Journal of infectious diseases. 2001, Vol 183, Num 4, pp 679-680, issn 0022-1899Article

A Randomized Study of Pharmacokinetics, Efficacy, and Safety of 2 Raltegravir Plus Atazanavir Strategies in ART-Treated AdultsCAREY, Dianne; PETT, Sarah L; BLOCH, Mark et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 2, pp 143-149, issn 1525-4135, 7 p.Article

Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapyWINSTON, Alan; DUNCOMBE, Chris; LI, Patrick C. K et al.Neuroradiology (Berlin. Print). 2012, Vol 54, Num 12, pp 1331-1339, issn 0028-3940, 9 p.Article

Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoirKOELSCH, Kersten K; BOESECKE, Christoph; EMERY, Sean et al.AIDS (London). 2011, Vol 25, Num 17, pp 2069-2078, issn 0269-9370, 10 p.Article

Plasma Levels of Soluble CD 14 Independently Predict Mortality in HIV InfectionSANDLER, Netanya G; WAND, Handan; NEATON, James D et al.The Journal of infectious diseases. 2011, Vol 203, Num 6, pp 780-790, issn 0022-1899, 11 p.Article

A Novel Chemokine-Receptor-5 (CCR5) Blocker, SCH532706, Has Differential Effects on CCR5⁺CD4⁺ and CCR5⁺CD8⁺ T Cell Numbers in Chronic HIV InfectionPETT, Sarah L; ZAUNDERS, John; BAILEY, Michelle et al.AIDS research and human retroviruses. 2010, Vol 26, Num 6, pp 653-661, issn 0889-2229, 9 p.Article

Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited settingMANGCLAVIRAJ, Somsamorn; KERR, Stephen J; CHAITHONGWONGWATTHANA, Surasith et al.International journal of STD & AIDS. 2008, Vol 19, Num 8, pp 529-532, issn 0956-4624, 4 p.Article

Pandemic influenza and critical infrastructure dependencies : Possible impact on hospitalsITZWERTH, Ralf L; MACINTYRE, C. Raina; SHAH, Smita et al.Medical journal of Australia. 2006, Vol 185, Num 10, issn 0025-729X, S70-S72, SUPArticle

Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapyWINSTON, Alan; BLOCH, Mark; CARR, Andrew et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 2, pp 380-387, issn 0305-7453, 8 p.Article

Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a thai population with HIV infectionUNGSEDHAPAND, Chaiwat; SRASUEBKUL, Preeyaporn; EMERY, Sean et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 2, pp 693-701, issn 1525-4135, 9 p.Article

Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapyMARTIN, Allison; MOORE, Cecilia; MALLON, Patrick W. G et al.AIDS (London). 2013, Vol 27, Num 15, pp 2403-2411, issn 0269-9370, 9 p.Article